These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31362893)

  • 1. Tacrolimus ameliorates the phenotypes of type 4 Bartter syndrome model mice through activation of sodium-potassium-2 chloride cotransporter and sodium-chloride cotransporter.
    Matsuura Y; Nomura N; Shoda W; Mori T; Isobe K; Susa K; Ando F; Sohara E; Rai T; Uchida S
    Biochem Biophys Res Commun; 2019 Sep; 517(2):364-368. PubMed ID: 31362893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of ClC-K and barttin in low potassium-induced sodium chloride cotransporter activation and hypertension in mouse kidney.
    Nomura N; Shoda W; Wang Y; Mandai S; Furusho T; Takahashi D; Zeniya M; Sohara E; Rai T; Uchida S
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29326302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired phosphorylation of Na(+)-K(+)-2Cl(-) cotransporter by oxidative stress-responsive kinase-1 deficiency manifests hypotension and Bartter-like syndrome.
    Lin SH; Yu IS; Jiang ST; Lin SW; Chu P; Chen A; Sytwu HK; Sohara E; Uchida S; Sasaki S; Yang SS
    Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17538-43. PubMed ID: 21972418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with 17-allylamino-17-demethoxygeldanamycin ameliorated symptoms of Bartter syndrome type IV caused by mutated Bsnd in mice.
    Nomura N; Kamiya K; Ikeda K; Yui N; Chiga M; Sohara E; Rai T; Sakaki S; Uchida S
    Biochem Biophys Res Commun; 2013 Nov; 441(3):544-9. PubMed ID: 24189473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Regulation of kidney on potassium balance and its clinical significance].
    Xie QH; Hao CM
    Sheng Li Xue Bao; 2023 Apr; 75(2):216-230. PubMed ID: 37089096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical importance of potassium intake and molecular mechanism of potassium regulation.
    Nomura N; Shoda W; Uchida S
    Clin Exp Nephrol; 2019 Oct; 23(10):1175-1180. PubMed ID: 31317362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the human Na-K-2Cl cotransporter (NKCC2) identified in Bartter syndrome type I consistently result in nonfunctional transporters.
    Starremans PG; Kersten FF; Knoers NV; van den Heuvel LP; Bindels RJ
    J Am Soc Nephrol; 2003 Jun; 14(6):1419-26. PubMed ID: 12761241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and analyses of R8L barttin knockin mouse.
    Nomura N; Tajima M; Sugawara N; Morimoto T; Kondo Y; Ohno M; Uchida K; Mutig K; Bachmann S; Soleimani M; Ohta E; Ohta A; Sohara E; Okado T; Rai T; Jentsch TJ; Sasaki S; Uchida S
    Am J Physiol Renal Physiol; 2011 Aug; 301(2):F297-307. PubMed ID: 21593186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barttin increases surface expression and changes current properties of ClC-K channels.
    Waldegger S; Jeck N; Barth P; Peters M; Vitzthum H; Wolf K; Kurtz A; Konrad M; Seyberth HW
    Pflugers Arch; 2002 Jun; 444(3):411-8. PubMed ID: 12111250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation of the Na(+)-K(+)-2Cl(-) cotransporter NKCC2 in mice is associated with severe polyuria and a urea-selective concentrating defect without hyperreninemia.
    Kemter E; Rathkolb B; Bankir L; Schrewe A; Hans W; Landbrecht C; Klaften M; Ivandic B; Fuchs H; Gailus-Durner V; Hrabé de Angelis M; Wolf E; Wanke R; Aigner B
    Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1405-15. PubMed ID: 20219826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inherited primary renal tubular hypokalemic alkalosis: a review of Gitelman and Bartter syndromes.
    Shaer AJ
    Am J Med Sci; 2001 Dec; 322(6):316-32. PubMed ID: 11780689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcineurin inhibitors block sodium-chloride cotransporter dephosphorylation in response to high potassium intake.
    Shoda W; Nomura N; Ando F; Mori Y; Mori T; Sohara E; Rai T; Uchida S
    Kidney Int; 2017 Feb; 91(2):402-411. PubMed ID: 28341239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal reabsorption of Na+/CI- by the thiazide-inhibitable transporter of the distal convoluted tubule in Gitelman's syndrome.
    Colussi G; Rombolà G; Brunati C; De Ferrari ME
    Am J Nephrol; 1997; 17(2):103-11. PubMed ID: 9096439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human and murine phenotypes associated with defects in cation-chloride cotransport.
    Delpire E; Mount DB
    Annu Rev Physiol; 2002; 64():803-43. PubMed ID: 11826289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse model of type II Bartter's syndrome. II. Altered expression of renal sodium- and water-transporting proteins.
    Wagner CA; Loffing-Cueni D; Yan Q; Schulz N; Fakitsas P; Carrel M; Wang T; Verrey F; Geibel JP; Giebisch G; Hebert SC; Loffing J
    Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1373-80. PubMed ID: 18322017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcineurin inhibitor cyclosporine A activates renal Na-K-Cl cotransporters via local and systemic mechanisms.
    Blankenstein KI; Borschewski A; Labes R; Paliege A; Boldt C; McCormick JA; Ellison DH; Bader M; Bachmann S; Mutig K
    Am J Physiol Renal Physiol; 2017 Mar; 312(3):F489-F501. PubMed ID: 28003191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse model of type II Bartter's syndrome. I. Upregulation of thiazide-sensitive Na-Cl cotransport activity.
    Cantone A; Yang X; Yan Q; Giebisch G; Hebert SC; Wang T
    Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1366-72. PubMed ID: 18385266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenylyl cyclase 6 enhances NKCC2 expression and mediates vasopressin-induced phosphorylation of NKCC2 and NCC.
    Rieg T; Tang T; Uchida S; Hammond HK; Fenton RA; Vallon V
    Am J Pathol; 2013 Jan; 182(1):96-106. PubMed ID: 23123217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel SLC12A1 (NKCC2) mutations in two families with Bartter syndrome type 1.
    Adachi M; Asakura Y; Sato Y; Tajima T; Nakajima T; Yamamoto T; Fujieda K
    Endocr J; 2007 Dec; 54(6):1003-7. PubMed ID: 17998760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies.
    Peters M; Jeck N; Reinalter S; Leonhardt A; Tönshoff B; Klaus G Gü; Konrad M; Seyberth HW
    Am J Med; 2002 Feb; 112(3):183-90. PubMed ID: 11893344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.